Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
PRX933
Cat. No.:
OB0425LY-001
Appearance:
Solid
Purity:
≥95%
Identity:
Confirmed by NMR.
Size:
Add to basket
Product Overview
Description:
PRX933 is a small molecule compound with potential anti-tumor and anti-obesity activity that acts primarily by targeting specific enzymes or receptors.
Synonyms:
313658-33-2; GW-876167; 2-[(2R)-2-Methylpiperazin-1-yl]-3-(2-pyridin-3-yloxyethoxy)pyrazine; (2R)-Methyl-1-{3-[2-(3-pyridinyloxy)ethoxy]-2-pyrazinyl}piperazine; (R)-2-(2-Methylpiperazin-1-yl)-3-(2-(pyridin-3-yloxy)ethoxy)pyrazine
CAS No.:
313658-33-2
Compound CID:
9818332
Formula:
C16H21N5O2
Formula Weight:
315.37
Specification
Target:
5-HT receptor
Pathway:
GPCR/G protein; Neuronal signaling
Storage:
Storage at -20°C.
Applications:
PRX933 can be used in the study of obesity, cancer and glaucoma.
